MedPath

Contingency Management for Recovery Oriented Activities at Recovery Houses

Not Applicable
Recruiting
Conditions
Substance Use Disorders
Interventions
Behavioral: Contingency management
Behavioral: Usual Care
Registration Number
NCT05585203
Lead Sponsor
Wayne State University
Brief Summary

In this study, the investigators will implement contingency management at rural recovery houses, where individuals with substance use disorders reside. Contingency management is a behavioral intervention in which participants receive incentives (rewards) when they complete planned tasks that are consistent with their recovery efforts. House staff members will also participate in this study and will be trained to provide contingency management to residents. The investigators will compare recovery houses that implement contingency management to matched houses that do not, and the main outcomes will be engagement in the planned activities and retention in the recovery houses. Participants will receive contingency management for up to 12 weeks and follow-up will occur 6 months post-treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria
  1. Age 18 or older;
  2. a resident of the recovery house; and
  3. able to provide informed consent.
Exclusion Criteria
  1. expected to be discharged from the recovery house in the next two months;
  2. experiencing uncontrolled mania, psychosis or suicidality.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Contingency managementUsual CareIn addition to receiving usual care at the recovery house, participants assigned to this arm will receive contingency management by trained recovery house staff in addition to their usual care. Contingency management sessions will be led by a trained recovery house staff member who is also a research participant in the study. Contingency management will occur once weekly for sessions of approximately 10-15 minute duration for up to 12 weeks. Participants will plan three recovery-oriented activities with the staff member each week, and upon verification of completion of the tasks, the resident participant can earn prize draws of varying monetary amounts.
Contingency managementContingency managementIn addition to receiving usual care at the recovery house, participants assigned to this arm will receive contingency management by trained recovery house staff in addition to their usual care. Contingency management sessions will be led by a trained recovery house staff member who is also a research participant in the study. Contingency management will occur once weekly for sessions of approximately 10-15 minute duration for up to 12 weeks. Participants will plan three recovery-oriented activities with the staff member each week, and upon verification of completion of the tasks, the resident participant can earn prize draws of varying monetary amounts.
Usual CareUsual CareParticipants in this arm will receive usual care that they would normally receive at the recovery houses. Recovery houses are safe, healthy, family-like substance-free living environments that support individuals in recovery from addiction. Although recovery residences vary considerably, this form of housing benefits individuals in recovery by reinforcing a substance-free lifestyle and providing direct connections to other peers in recovery, mutual support groups and recovery support services.
Primary Outcome Measures
NameTimeMethod
Engagement in recovery-oriented activitiesup to 12 week treatment

Participants will engage in up to 3 planned recovery activities (noted on a tracking form)

Treatment retentionTime until leaving the recovery home from study baseline up to one year

Length of time (in days) a resident resides in the recovery house

Secondary Outcome Measures
NameTimeMethod
Quality of Life AssessmentBaseline, post-treatment (week 12) and 6-month follow up

Self-report Quality of Life inventory (scores range from -3 to 3 with higher scores reflecting greater quality of life)

Substance UseBaseline, weekly for 12 weeks, post-treatment (week 12) and 6-month follow up

Urine drug screen of metabolites for cocaine, methamphetamine, barbiturates, opioids, cannabis, alcohol and benzodiazepines

Timeline Follow-back for substance useBaseline, weekly for 12 weeks, post-treatment (week 12) and 6-month follow up

Timeline Follow-back (TLFB) is a self-report, calendar-based measure of the frequency of substance use

Self-Reported HealthBaseline, post-treatment (week 12) and 6-month follow up

Short Form 36 (SF-36) is a brief measure of overall self-reported health. Scores range from 0 (maximum disability) to 100 (no disability)

Treatment SatisfactionPost-treatment (Week 12)

Treatment Satisfaction Questionnaire (Scores range from 1 to 7 with higher scores reflecting greater satisfaction)

Patient Health Questionnaire - 9Baseline, post-treatment (week 12) and 6-month follow up

A measure of depression symptoms. Scores on the PHQ 9 range from 0 (no depression) to 27 (severe depression).

Treatment FeasibilityBaseline

Treatment Feasibility will assessed as the proportion of eligible participants who are willing to participate after initial screening.

Trial Locations

Locations (1)

Wayne State University School of Medicine

🇺🇸

Detroit, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath